Showing results (211-220 of 263) with videos related to

Sort By:
Pageof 27
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 30, 2010
Membrane-associated activation of cholesterol α-glucosyltransferase, an enzyme responsible for biosynthesis of cholesteryl-α-D-glucopyranoside in Helicobacter pylori critical for its survivalHitomi Hoshino, Akiko Tsuchida, Kiyokazu Kametani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 2022
[Wasted Anti-Cancer Agents Due to Cancellations after Dispensing]Minoru Fukuda, Takuya Honda, Takahiro Uchida, et al.
International Journal of Cancer|December 18, 2009
Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumorShingo Hatakeyama, Atsushi Kyan, Hayato Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2011
Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptideShingo Hatakeyama, Kazuhiro Sugihara, Toshiaki K Shibata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[Efforts toward Venous Access of Anti-Cancer Drug by Nurses]Kazue Suzuki, Akemi Tsuchiya, Erika Nakamura, et al.
Thoracic Cancer|May 29, 2020
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II studyTakaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Trends in Outpatient Chemotherapy for Thoracic Oncology]Minoru Fukuda, Hiroyuki Yamaguchi, Shinnosuke Takemoto, et al.
Thoracic Cancer|January 11, 2019
Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNAShinnosuke Takemoto, Yoichi Nakamura, Hiroshi Gyoutoku, et al.
The Journal of Clinical Investigation|February 7, 2012
Essential role of gastric gland mucin in preventing gastric cancer in miceFumitoshi Karasawa, Akira Shiota, Yukinobu Goso, et al.
Thoracic Cancer|November 20, 2020
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutationYosuke Dotsu, Minoru Fukuda, Noritaka Honda, et al.
Pageof 27